Date:10/1/2008

ts of calorie restriction is resveratrol, a natural ingredient found in red wine. Since then, Sirtris has developed its own proprietary formulation of resveratrol, SRT501. Early clinical studies in patients with Type 2 Diabetes indicate that SRT501 may lower glucose and improve insulin sensitivity. Sirtris also has new chemical entities (NCEs) which are structurally unrelated to and one-thousand times more potent than resveratrol. Sirtris' first new chemical entity is currently being evaluated for safety and tolerability in a Phase 1a study in humans.

"We are beginning to understand more about activation of other enzymes in the sirtuin family, SIRT2-7, and we're encouraged by early data that indicates a role for other sirtuins in multiple therapeutic areas," continued Dr. Westphal.

'/>"/>

Contact: Caton Lovett caton@purecommunicationsinc.com 910-509-3975 Pure Communications Inc. Source:Eurekalert

1 GOOD

Page: 1 2
Related biology news :

1. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
2. Review article provides tools for the Rosaceae genomics community
3. Medicines derived from cannabis: a review of adverse events
4. Stanford researchers publish review of US medical device regulation
5. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
6. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
7. Michael J. Fox Foundation PD Therapeutics Conference
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. Iron-moving malfunction may underlie neurodegenerative diseases, aging
10. Gaining a better understanding of kidney diseases
11. Biodegradable polymers show promise for improving treatment of acute inflammatory diseases